1. Home
  2. KRYS vs SYM Comparison

KRYS vs SYM Comparison

Compare KRYS & SYM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRYS
  • SYM
  • Stock Information
  • Founded
  • KRYS 2015
  • SYM 2005
  • Country
  • KRYS United States
  • SYM United States
  • Employees
  • KRYS N/A
  • SYM N/A
  • Industry
  • KRYS Biotechnology: Biological Products (No Diagnostic Substances)
  • SYM Industrial Machinery/Components
  • Sector
  • KRYS Health Care
  • SYM Industrials
  • Exchange
  • KRYS Nasdaq
  • SYM Nasdaq
  • Market Cap
  • KRYS 4.7B
  • SYM 5.4B
  • IPO Year
  • KRYS 2017
  • SYM N/A
  • Fundamental
  • Price
  • KRYS $183.36
  • SYM $63.10
  • Analyst Decision
  • KRYS Strong Buy
  • SYM Hold
  • Analyst Count
  • KRYS 9
  • SYM 13
  • Target Price
  • KRYS $203.22
  • SYM $41.00
  • AVG Volume (30 Days)
  • KRYS 384.0K
  • SYM 2.1M
  • Earning Date
  • KRYS 11-03-2025
  • SYM 11-17-2025
  • Dividend Yield
  • KRYS N/A
  • SYM N/A
  • EPS Growth
  • KRYS 36.22
  • SYM N/A
  • EPS
  • KRYS 4.91
  • SYM N/A
  • Revenue
  • KRYS $359,205,000.00
  • SYM $2,193,031,000.00
  • Revenue This Year
  • KRYS $34.33
  • SYM $25.99
  • Revenue Next Year
  • KRYS $47.84
  • SYM $20.28
  • P/E Ratio
  • KRYS $37.38
  • SYM N/A
  • Revenue Growth
  • KRYS 116.08
  • SYM 35.75
  • 52 Week Low
  • KRYS $122.80
  • SYM $16.32
  • 52 Week High
  • KRYS $207.84
  • SYM $65.17
  • Technical
  • Relative Strength Index (RSI)
  • KRYS 76.57
  • SYM 66.94
  • Support Level
  • KRYS $158.08
  • SYM $52.35
  • Resistance Level
  • KRYS $183.36
  • SYM $54.79
  • Average True Range (ATR)
  • KRYS 6.02
  • SYM 3.61
  • MACD
  • KRYS 2.37
  • SYM 1.07
  • Stochastic Oscillator
  • KRYS 99.31
  • SYM 88.01

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

About SYM Symbotic Inc.

Symbotic Inc is an automation technology company that develops technologies to improve operating efficiencies in modern warehouses. The group develops, commercializes, and deploys end-to-end technology solutions that dramatically improve supply chain operations. Th company also automates the processing of pallets and cases in large warehouses or distribution centers for some of the retail and wholesale companies in the world. The company operates in two geographical regions the United States and Canada. Key revenue is generated from the United States.

Share on Social Networks: